{"id":752285,"date":"2023-04-27T17:07:05","date_gmt":"2023-04-27T21:07:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/"},"modified":"2023-04-27T17:07:05","modified_gmt":"2023-04-27T21:07:05","slug":"ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/","title":{"rendered":"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NOVATO, Calif., April  27, 2023  (GLOBE NEWSWIRE) &#8212; Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, May 4, 2023, to discuss its financial results and corporate update for the quarter ending March 31, 2023.<\/p>\n<p>The live and replayed webcast of the call will be available through the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O8_pvkOJr0GIWnvZBRvHTa1c9PjLWiAJlOI-8usax3YcETvAOR8FL0Fp_03BqrodxjCQITWD41zpxWRFW4wCxy6pOSDeUNyrWzoHyIjhsaq74a5O4mw_i6n1LH7lCn3VnukKtzHCZnHFninGmkGcv0wyq2MZmfH7-S9ly6cOBNU=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.ultragenyx.com\/events-presentations<\/a>. To participate in the live call, please register by clicking on the following link (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MKGDY_Z5dqfVVcLfNwq5bnI5SbIAr3YeExYMODE_5sjcLtd7YopiMOSs9Al0s4kGdlsWXvDcUl7j83r8TQvy-xt14K4gBwRi-ugUwxv4PW1k6HVBtL4aX5KfbQL55lIbFhaJpEf6Akx7wze9R0KFu-aoe1ngW64stDLBxeFYHLssOgu8RqRmMCxnEiFeB8P5DpbGHlElf8jstU1rVDjgLKg53SMpNV-GQkVGHNzwiOGAN17tnzpsGw3nzQwvjrvbyBinBUHsHkLFLxfivJWZYn082o0TF5_5Hs6TWCjd_Jg=\" rel=\"nofollow noopener\" target=\"_blank\">registration link<\/a>) and you will be provided with dial-in details. The replay of the call will be available for one year.<\/p>\n<p>\n        <strong>About\u00a0Ultragenyx Pharmaceutical Inc.<\/strong>\n      <\/p>\n<p>Ultragenyx is a biopharmaceutical company committed to bringing novel therapies to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved medicines and treatment candidates aimed at addressing diseases with high unmet medical need and clear biology, for which there are typically no approved therapies treating the underlying disease.<\/p>\n<p>The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx\u2019s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.<\/p>\n<p>For more information on Ultragenyx, please visit the company&#8217;s website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yIq_Wx22X2E1sC3AFFSnBNm7ipovx5cLAjzMdldwfg-8iYrt3uKYWH0bpK2XcecxrqTOy22o8YfySKQdzP9JBZFT5xDilBb6rwk1YbKI1SM=\" rel=\"nofollow noopener\" target=\"_blank\">www.ultragenyx.com<\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong><br \/>\n        <br \/>\n        <u>Ultragenyx Pharmaceutical, Inc.<\/u><br \/>\n        <br \/>Investors<br \/>Joshua Higa<br \/>415-475-6370<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eu2vsESnX5uGrpWLOz0nFgvx4PUZGJlyM4nk7ZWzppqBz4EYhpvYa9Df4_kP0QpsYI_rCbUyGs96-Av64d7Lnw==\" rel=\"nofollow noopener\" target=\"_blank\">IR@ultragenyx.com<\/a><\/p>\n<p>Media<br \/>Jeff Blake<br \/>415-612-7784<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iy8tlrLv9G0rKgH2752E_2dC7mAr4bt5FiDrhf1PCTjO1Yl8mE4xCutdXsW_qqGK8GF93qix-F5L4ltKWgGDf8zBO6WsQLyt-gMdOz_VWvA=\" rel=\"nofollow noopener\" target=\"_blank\">media@ultragenyx.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NzA3NTc3YTUtYTg0MC00MDcyLWE0ZmUtZmE0ZjBmNTkwOTdkLTEwMjA4NjQ=\/tiny\/Ultragenyx-Pharmaceutical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NOVATO, Calif., April 27, 2023 (GLOBE NEWSWIRE) &#8212; Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, May 4, 2023, to discuss its financial results and corporate update for the quarter ending March 31, 2023. The live and replayed webcast of the call will be available through the company\u2019s website at https:\/\/ir.ultragenyx.com\/events-presentations. To participate in the live call, please register by clicking on the following link (registration link) and you will be provided with dial-in details. The replay of the call will be available for one year. About\u00a0Ultragenyx Pharmaceutical Inc. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-752285","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NOVATO, Calif., April 27, 2023 (GLOBE NEWSWIRE) &#8212; Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, May 4, 2023, to discuss its financial results and corporate update for the quarter ending March 31, 2023. The live and replayed webcast of the call will be available through the company\u2019s website at https:\/\/ir.ultragenyx.com\/events-presentations. To participate in the live call, please register by clicking on the following link (registration link) and you will be provided with dial-in details. The replay of the call will be available for one year. About\u00a0Ultragenyx Pharmaceutical Inc. &hellip; Continue reading &quot;Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T21:07:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update\",\"datePublished\":\"2023-04-27T21:07:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/\",\"name\":\"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=\",\"datePublished\":\"2023-04-27T21:07:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/","og_locale":"en_US","og_type":"article","og_title":"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update - Market Newsdesk","og_description":"NOVATO, Calif., April 27, 2023 (GLOBE NEWSWIRE) &#8212; Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, May 4, 2023, to discuss its financial results and corporate update for the quarter ending March 31, 2023. The live and replayed webcast of the call will be available through the company\u2019s website at https:\/\/ir.ultragenyx.com\/events-presentations. To participate in the live call, please register by clicking on the following link (registration link) and you will be provided with dial-in details. The replay of the call will be available for one year. About\u00a0Ultragenyx Pharmaceutical Inc. &hellip; Continue reading \"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-27T21:07:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update","datePublished":"2023-04-27T21:07:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/","name":"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=","datePublished":"2023-04-27T21:07:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUyOCM1NTYyNzgxIzIwMDkyOTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ultragenyx-to-host-conference-call-for-first-quarter-2023-financial-results-and-corporate-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ultragenyx to Host Conference Call for First Quarter 2023\u00a0Financial Results and Corporate Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=752285"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752285\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=752285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=752285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=752285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}